InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Pushkal Garg, a CMO & EVP Dev & Med Affairs, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 29 open-market SEC Form 4 transactions: 0 purchases worth $0 and 29 sales worth $27.4M, reported from Mar 3, 23 to Mar 5, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 740 | $326.08 | $239K |
| Mar 4, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 767 | $325.67 | $248K |
| Mar 3, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 640 | $321.50 | $205K |
| Mar 2, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 421 | $332.64 | $138K |
| Feb 27, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 2.3K | $334.39 | $747K |
| Feb 13, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 2.2K | $310.08 | $695K |
| Jan 12, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 220 | $377.82 | $80K |
| Oct 3, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 898 | $454.37 | $406K |
| Oct 2, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 668 | $457.64 | $302K |
| Aug 19, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 338 | $461.74 | $155K |
| Aug 18, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 543 | $455.82 | $247K |
| Mar 24, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 5.4K | $300.00 | $1.6M |
| Mar 21, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 4.3K | $285.00 | $1.2M |
| Mar 4, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 343 | $242.70 | $83K |
| Mar 3, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 583 | $248.36 | $142K |
| Feb 28, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 352 | $244.11 | $85K |
| Feb 18, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 862 | $259.10 | $216K |
| Feb 14, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 386 | $264.87 | $98K |
| Jan 27, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 52.6K | $285.00 | $15.0M |
| Dec 12, 24 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 778 | $255.80 | $196K |
| Nov 26, 24 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 945 | $252.27 | $238K |
| Jun 25, 24 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 398 | $235.19 | $92K |
| Feb 28, 24 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 247 | $158.09 | $38K |
| Feb 16, 24 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 672 | $149.03 | $100K |
| Aug 7, 23 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 3.1K | $185.32 | $571K |
| Aug 4, 23 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 1.6K | $189.31 | $296K |
| Apr 28, 23 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 955 | $201.30 | $191K |
| Apr 27, 23 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 779 | $197.08 | $152K |
| Mar 3, 23 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 18.1K | $200.00 | $3.6M |